Deeks S G, Grant R M
University of California and San Francisco General Hospital, San Francisco, California, USA.
Antivir Ther. 1999;4 Suppl 3:7-11.
This article explores current controversies related to 'discordant' responses to antiviral therapy, that is to say, patients with a sustained CD4 cell response despite virological failure. Observational clinical data of patients receiving protease inhibitor-based therapy who had a sustained CD4 cell count even with incomplete viral suppression will be presented, as well as possible mechanisms and clinical implications.
